NTI’s trial of Autism treatment in children shows further patient improvement after 12 weeks.

There are currently no approved treatments available to help children with Autism Spectrum Disorder (ASD). Our biotech Investment Neurotech International (ASX: NTI) is looking to change this.

Comments

  • No comments yet.
  • Add a comment